Kyndryl Partners with Dr Reddys to Automate Global IT Operations

Kyndryl, a top mission-critical enterprise technology services company, has entered into a strategic association with Dr. Reddy's Laboratories, a leading Indian multinational pharmaceutical firm, to transform and simplify the latter's worldwide IT

India Gets Targeted IDH1 Therapy as Servier Rolls Out Ivosidenib

Servier India, the Indian subsidiary of French multinational pharmaceutical company Servier Group, has rolled out Ivosidenib, an oral targeted treatment for IDH1-mutated acute myeloid leukaemia

India Gets Its First Bluetooth CGM as Tracky Redefines Diabetes Monitoring

Tracky, a brand of DrStore Healthcare Services and a health tech startup, launched India's first Bluetooth Continuous Glucose Monitor

NPPA Permits Torrent to Shift Drug Production from Akums to Sikkim

At the retail price previously authorized by the National Pharmaceutical Pricing Authority ( NPPA), Torrent Pharmaceuticals has been permitted to move the manufacturing of its combination medication for nutritional

Dr Reddy's Partners with Alvotech to Expand in Oncology Biosimilars

Dr Reddy's Laboratories has made a strategic partnership with global biotechnology company Alvotech for the co-development and commercialization of a biosimilar of Keytruda

API Prices Plunge, Easing Costs for Indian Pharma Manufacturers

A significant drop is being seen in the prices of active pharmaceutical ingredients (API) used for manufacturing drugs, bringing relief to India's pharmaceutical industry. China is largely depended upon the pharma industry for sourcing APIs

CDSCO Clears Phase III Trial of Tetanus Vaccine in Pregnant Women

The major boost for maternal immunization in New Delhi, the Subject Expert Committee (SEC) on Vaccines of the Central Drugs Standard Control Organisation

BioNTech, BMS Partner to Advance BNT327 in Solid Tumor Cancers

An agreement has been reached between BioNTech and Bristol Myers Squibb for the worldwide co-development and co-commercialization of BioNTech's investigational bispecific antibody BNT327 across a variety of solid tumor types.

NPPA Regulates 41 Drug Combinations to Curb Healthcare Costs

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price ceilings on 41 combinations of drugs, including 18 types of Boehringer Ingelheim's

ASPA marks World Anti-Counterfeiting Day with major industry initiative

The Authentication Solution Providers’ Association (ASPA) ahead of World Anti-Counterfeiting Day, has commissioned the second edition of its flagship industry report, ‘State of Counterfeiting in India – 2025

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.